The central nervous system can be affected by numerous forms of vasculitis, most of which are secondary to a known underlying disease. In this review I concentrate on primary angiitis of the central nervous system with only a brief account of secondary syndromes.
Primary angiitis of the central nervous system (PACNS) is a rare disease to which the terms granulomatous angiitis and isolated cerebral vasculitis have also been applied; neither is appropriate since PACNS can be granulomatous or lymphocytic 1 , and involvement of extracranial arteries (e.g. pulmonary and abdominal visceral angiitis) has been reported 2 . Most commonly small and medium vessels are involved, although an artery or vein of any size may be affected 3 . There is segmental in¯ammation and necrosis of leptomeningeal and parenchymal blood vessels and the in®ltrate consists of macrophages, multinucleated giant cells (not always present), lymphocytes and polymorphonuclear leukocytes 4, 5 . Surrounding brain tissue may show ischaemic necrosis, evolving haemorrhagic infarcts and reactive astrocytosis 6 . Blood vessels in any part of the central nervous system can be affected but there is a predilection for leptomeningeal vessels. Skipped lesions are common.
The aetiology and pathogenesis are unknown. Particles resembling mycoplasma 7 or virus-like structures 8 have been described. Associations with herpes zoster 9 , Hodgkin's disease 10 , selective IgA de®ciency 11 , acquired immuno-de®ciency syndrome 12 , phenylpropanolamine use 13 , and amphetamine and cocaine abuse 14 have been reported.
SECONDARY VASCULITIS
Box 1 lists the main causes of secondary vasculitis in the central nervous system. One of the more important is giantcell arteritis. The super®cial temporal, vertebral, ophthalmic and posterior ciliary arteries are more often affected than the external and internal carotids, intracranial arteries almost never. In Takayasu's arteritis syncope and visual defects are the main neurological features. They are usually secondary to hypertension through involvement of the renal arteries. Transient ischaemic attack (TIA) or stroke is rare 15 . Neurological abnormalities are found in a quarter to half of patients with polyarteritis nodosa, more commonly in the peripheral than the central nervous system. CNS involvement can result in TIA, stroke, seizure or encephalopathy 15 . The frequency of cerebral vasculitis in Churg±Strauss syndrome is similar to that in polyarteritis nodosa; stroke or ischaemic optic neuropathy can occur 16 . The prevalence of CNS involvement in Wegener's granulomatosis has varied from 11% to 44%. Stroke may result from hypertensive small-vessel disease or rarely small-vessel vasculitis 17 . Cerebral vasculitis is uncommon in hypersensitivity angiitis, microscopic polyangiitis, Henoch± Scho Ènlein purpura and essential cryoglobulinaemia 15 by stroke 18 and CNS vasculitis is found in 12.5% of cases; however, the most common cause of stroke is embolism from cardiac mural thrombi 19 . A prothrombotic state is another important mechanism of stroke. Intracerebral haemorrhage is the most common, followed by subarachnoid and spinal subdural.
Lymphoproliferative disorders are present in a substantial proportion of these who bleed . Intracranial space-occupying lesions are present in 15% of cases. Focal and diffuse CNS symptoms and headaches are the common presentations. The diagnosis is usually established when a brain biopsy to assess the neoplastic lesion unexpectedly reveals vasculitis.
Diagnosis
Because of the lack of typical or pathognomonic features, diagnosis is dif®cult. Angiitis is suspected when neurological signs and symptoms remain unexplained or when the angiographic appearance is consistent with arteritis. Diseases associated with CNS vasculitis, such as herpes zoster, syphilis, tuberculosis, fungal infections, Hodgkin's disease, SLE, rheumatoid arthritis, scleroderma, systemic necrotizing vasculitis, Wegener's granulomatosis, lymphoid granulomatosis and cocaine/amphetamine abuse should be carefully excluded. Atrial myxoma and atrium-derived emboli, as well as cholesterol embolism syndrome, are among the conditions that can simulate vasculitis (Box 2).
Routine laboratory tests usually give normal results. The erythrocyte sedimentation rate may be raised but more often is not. Cerebrospinal¯uid is abnormal in 80±90% of pathologically documented cases: mild lymphocytosis and an increased protein are the usual ®ndings, occasionally with oligoclonal bands; culture for CNS infection is always advisable. Abnormal cerebral accumulation of infused indium-labelled leukocytes may provide useful clues to the diagnosis; cerebral perfusion SPECT, although non-speci®c, may also be useful, and likewise ophthalmic videomicroscopy and low-dose¯uorescein angiography of the anterior chamber. Findings on computed tomography tend to be non-speci®c, with areas of low density, mass effect and cerebral atrophy. However, multifocal lesions that do not conform to major vascular territories may be useful. Lumbar puncture and magnetic resonance imaging, thought non-speci®c, have high negative predictive value. MRI characteristically reveals multiple bilateral supratentorial high intensity lesions and is very rarely completely normal in the presence of cerebral angiitis. Cerebral angiography alone can not exclude or establish a diagnosis of isolated cerebral vasculitis. A 30±45% falsenegative rate has been reported, presumably because the affected vessels were too small to be visualized 20 . The characteristic appearance of cerebral vasculitis is a pattern of symmetrical narrowing, or beading, with multiple areas of involvement. If the angiogram is negative, brain biopsy may be contemplated, though it too can be falsely negative. Leptomeninges are almost always involved by vasculitis in CNS, so leptomeningeal biopsy has been advocated, but appropriate specialist referral should always be obtained ®rst.
Treatment
High-dose corticosteroids are the mainstay of treatment. Cyclophosphamide may give additional bene®t 21 ; because of the rarity of the condition, formal prospective therapeutic trials are unlikely. One recommendation is early recourse to cyclophosphamide in patients not responding rapidly to high-dose steroids. The Arthritis and Rheumatism Council recommends that cyclophosphamide should be intermittent, because of the risk of bladder toxicity with continuous oral treatment; steroid therapy is not recommended alone because of the high risk of relapse and the long-term complications 22 . For patients with an acute focal presentation with normal cerebrospinal¯uid and a diagnosis based on angiography alone, a course of high-dose corticosteroids in conjunction with calcium channel blockers is proposed.
